Literature DB >> 8323981

Schizophrenia and oestrogens--is there an association?

A Riecher-Rössler1, H Häfner.   

Abstract

Some early psychiatrists already believed that schizophrenic disorders were associated with a disturbed balance of sexual hormones. This belief was based on the observation of a. an "insufficient functioning of the sexual glands" with so-called "hypoestrogenism", and b. an influence of ovarian function on schizophrenic psychoses. As this review shows, there are findings from recent research which seem to confirm that estrogens may have a protective effect in schizophrenia. There are also occasional hints at a possible "hypoestrogenism" in schizophrenia. In our own epidemiological, clinical and animal studies the hypothesis of a protective effect of oestrogens was for the first time systematically examined and confirmed. Oestrogens seem to modulate the sensitivity of D2-receptors in the brain, and clinically they seem to have a neuroleptic-like effect. These findings may have important implications for the prevention and therapy of schizophrenic disorders. Furthermore, our findings indicate the need to reinvestigate the question of a disturbed balance of sexual hormones in schizophrenic disorders. Further research on the role of oestrogens in schizophrenic disorders could in our opinion contribute to understanding the still unclear, possibly aetiologically heterogeneous pathogenetic mechanism of schizophrenic psychoses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8323981     DOI: 10.1007/bf02190244

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  40 in total

1.  Estrogens in tardive dyskinesia in male psychiatric patients.

Authors:  A Villeneuve; T Cazejust; M Côté
Journal:  Neuropsychobiology       Date:  1980       Impact factor: 2.328

2.  Effects of catechol estrogens and catecholamines on hypothalamic and corpus striatal tyrosine hydroxylase activity.

Authors:  M M Foreman; J C Porter
Journal:  J Neurochem       Date:  1980-05       Impact factor: 5.372

3.  [Effects of depot neuroleptics on pituitary hormone secretion (author's transl)].

Authors:  A Czernik; K Kleesiek
Journal:  Nervenarzt       Date:  1979-08       Impact factor: 1.214

4.  Changes in MAO activity during estrogen treatment of females with endogenous depression.

Authors:  F Holsboer; O Benkert; L Demisch
Journal:  Mod Probl Pharmacopsychiatry       Date:  1983

5.  Oestrogens and extrapyramidal system.

Authors:  P Bedard; P Langelier; A Villeneuve
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

6.  Oestrogens, dopamine and mood.

Authors:  J Cookson
Journal:  Br J Psychiatry       Date:  1981-10       Impact factor: 9.319

7.  Neuroendocrine effects of haloperidol therapy in chronic schizophrenia.

Authors:  F Brambilla; A Guerrini; A Guastalla; C Rovere; F Riggi
Journal:  Psychopharmacologia       Date:  1975-10-14

Review 8.  Role of female gonadal hormones in the CNS: clinical and experimental aspects.

Authors:  A Maggi; J Perez
Journal:  Life Sci       Date:  1985-09-09       Impact factor: 5.037

Review 9.  Endocrine aspects of postnatal mental disorders.

Authors:  A Wieck
Journal:  Baillieres Clin Obstet Gynaecol       Date:  1989-12

10.  Psychosis and pregnancy.

Authors:  S S Chang; D C Renshaw
Journal:  Compr Ther       Date:  1986-10
View more
  19 in total

1.  Treatment with phytoestrogens for depressive symptoms in late-onset schizophrenia:a case report.

Authors:  Gopalkumar Rakesh; Naren P Rao; Ganesan Venkatasubramanian; Rishikesh V Behere; Shivarama Varambally; Bangalore N Gangadhar
Journal:  Prim Care Companion CNS Disord       Date:  2011

2.  Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-07-07       Impact factor: 7.853

3.  Diagnosing cycloid psychosis.

Authors:  L C Kopala
Journal:  J Psychiatry Neurosci       Date:  1998-09       Impact factor: 6.186

4.  The role of estrogen in schizophrenia.

Authors:  M V Seeman
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

Review 5.  Role of estrogen treatment in the management of schizophrenia.

Authors:  Jayashri Kulkarni; Emmy Gavrilidis; Roisin Worsley; Emily Hayes
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

Review 6.  Neuropsychiatric effects of tamoxifen: Challenges and opportunities.

Authors:  Andrew M Novick; Anthony T Scott; C Neill Epperson; Christopher D Schneck
Journal:  Front Neuroendocrinol       Date:  2020-08-18       Impact factor: 8.606

7.  Association Between Age at Onset of Schizophrenia and Age at Menarche.

Authors:  Esin Evren Kiliçaslan; Almila Erol; Burçak Zengin; Pınar Çetinay Aydin; Levent Mete
Journal:  Noro Psikiyatr Ars       Date:  2014-09-01       Impact factor: 1.339

8.  Menstrual Cycle in Schizophrenic Patients: Review with a Case.

Authors:  İpek Sönmez; Ferdi Köşger
Journal:  Noro Psikiyatr Ars       Date:  2015-12-01       Impact factor: 1.339

Review 9.  Estrogen control of central neurotransmission: effect on mood, mental state, and memory.

Authors:  G Fink; B E Sumner; R Rosie; O Grace; J P Quinn
Journal:  Cell Mol Neurobiol       Date:  1996-06       Impact factor: 5.046

10.  Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.

Authors:  Deborah J Walder; Carrie W Holtzman; Jean Addington; Kristin Cadenhead; Ming Tsuang; Barbara Cornblatt; Tyrone D Cannon; Thomas H McGlashan; Scott W Woods; Diana O Perkins; Larry J Seidman; Robert Heinssen; Elaine F Walker
Journal:  Schizophr Res       Date:  2013-01-20       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.